Choate Partners Named Life Sciences Stars

Four partners – Dr. Brenda Herschbach Jarrell, Dr. Charles Lyon, Eric J. Marandett, and Dr. Rolando Medina– have been included in the LMG Life Sciences 2018 rankings of “Life Sciences Stars.”

According to the publication, the Firm is lauded by peers and clients as “…a go-to firm for non-contentious patent matters in the life sciences arena, including strategic portfolio management and prosecution.” LMG states that according to one pharmaceutical client, Choate’s “.. IP group offers a deep bench of attorneys who are notably well-versed in the biotechnology and pharmaceutical areas….they are not only knowledgeable, but are responsive and problem solvers.”

Dr. Jarrell is co-chair of the Life Sciences and Intellectual Property Groups. Described by clients as an IP lawyer with keen business savvy, her extensive technical credentials make her well versed in a wide variety of technologies in the biotech, pharmaceutical, and specialty chemical industries. She represents companies and institutions at all stages of the life sciences business lifecycle, as well as those who invest in them, guiding IP protection and competitive positioning strategies, negotiating strategic transactions, and providing creative solutions to IP and technology-related challenges.

Dr. Lyon is co-chair of the Intellectual Property Group. His practice spans all areas of patent protection and counseling with a particular focus on IPRs, reexaminations, IP due diligence, and freedom-to-operate or landscape analyses. He is particularly sought after for his deep knowledge of various cell and gene therapy landscapes and for his efficiency and ability to clearly communicate those issues that are most likely to affect the overall valuation of the underlying transaction or the risks associated with a particular IP dispute. His background as a chemist means that he is also routinely called upon by clients in the pharmaceutical and chemical industries.

Mr. Marandett is co-chair of the Intellectual Property Litigation Group. He represents biotech, pharmaceutical, and technology companies in high stakes patent litigation and other intellectual property and commercial disputes. He is a seasoned trial lawyer who brings strong business acumen and courtroom skills to every litigation he handles.

Dr. Medina has broad experience in intellectual property, including patent prosecution, opinions, due diligence studies, IP counseling and licensing in biotechnology and the medical sciences. He has experience representing academic universities and start-up companies, as well as mid-sized and large biotechnology and pharmaceutical companies. In 2017, he was named to Who’s Who Legal’s list of top Life Sciences transactional attorneys.

The Legal Media Group publishes the LMG Life Sciences guide annually in association with Euromoney Institutional Investor. The guide is based on nearly 1,000 interviews and surveys completed by partners active in the market, interviews with clients and leading lawyers, and a review of public information.